Connection
Richard Allen to Isoquinolines
This is a "connection" page, showing publications Richard Allen has written about Isoquinolines.
|
|
Connection Strength |
|
 |
|
 |
|
1.077 |
|
|
|
-
Allen RM, Uban KA, Atwood EM, Albeck DS, Yamamoto DJ. Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats. Pharmacol Biochem Behav. 2007 Nov; 88(1):82-8.
Score: 0.286
-
Allen RM, Dykstra LA, Carelli RM. Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats. Psychopharmacology (Berl). 2007 Apr; 191(2):341-51.
Score: 0.276
-
Allen RM, Carelli RM, Dykstra LA, Suchey TL, Everett CV. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement. J Pharmacol Exp Ther. 2005 Oct; 315(1):449-57.
Score: 0.248
-
Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov; 307(2):785-92.
Score: 0.219
-
Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb; 300(2):435-41.
Score: 0.049